PATENT CLAIM ANALYSIS

Application Number: 15884915
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-08
Patent Classification: ["514", "676000"]

Abstract:
The present invention relates to a method of treating or preventing cellular dysfunction and death caused by genetic, degenerative, toxic, traumatic, ischemic, infectious, neoplastic and inflammatory diseases and aging—and their neurological symptoms and manifestations, which includes administering d-methadone, beta-d-methadol, alpha-l-methadol, beta-l-methadol, alpha-d-methadol, acetylmethadol, d-alpha-acetylmethadol, l-alpha-acetylmethadol, beta-d-acetylmethadol, beta-l-acetylmethadol, d-alpha-normethadol, l-alpha normethadol, noracetylmethadol, dinoracetylmethadol, methadol, normethadol, dinormethadol, EDDP, EMDP, d-isomethadone, normethadone, N-methyl-methadone, N-methyl-d-methadone, N-methyl-l-methadone, l-moramide, levopropoxyphene, pharmaceutically acceptable salts, or mixtures thereof, including deuterated and tritium analogues, whether isolated from its enantiomer or synthesized de novo.

Claim (Index 14):
The method of  claim 1 , wherein the symptom or manifestation of nervous system disorders is chosen from a decline, impairment, or abnormality in cognitive abilities chosen from executive function, attention, cognitive speed, memory, language functions, orientation in space and time, praxis, ability to perform actions, ability to recognize faces or objects, concentration, and alertness; abnormal movements chosen from akathisia, bradykinesia, tics, myoclonus, dyskinesias, dystonias, tremors, and restless leg syndrome; parasomnias; insomnia; disturbed sleep pattern; psychosis; delirium; agitation; headache; motor weakness; spasticity; impaired physical endurance; sensory impairment; dysesthesias; dysautonomia; ataxia; impairment of balance or coordination; tinnitus; neuro-otological and eye movement impairments; neurological symptoms and manifestations of alcohol withdrawal, chosen from delirium, headache, tremors, and hallucinations; impaired social skills, hyperventilation; apnea; hand wringing; scoliosis; microcephaly; and self injurious behavior chosen from trichotillomania, dermotillomania, nail biting; and itching.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 86.0
- Lexical Diversity: 1.53165
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13803375', '15204052', '11527757', '13344393', '15579461']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7883076482885167
- 35 USC 102 Novelty (BERT): 0.5449190592309484
- Combined Prediction Score: 0.7639687893827599
- Mean Citation Score: 297.347038
- Max Citation Score: 403.17282
- Similarity Product: 279.02900718043327

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test